Abbarna A. Cumaraswamy

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

H. Maeda, T. Lion, M. Konopleva, 2017, Haematologica.

Verdazyl Radicals as Substrates for Organic Synthesis: The Synthesis and Characterization of [12]-, [13]-, and [21]-Paraheteraphanes

M. Georges, G. Hamer, Abbarna A. Cumaraswamy, 2012 .

Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Jisung Park, R. Moriggl, G. Keserű, 2018, Leukemia.

Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein

David E. Muench, X. Cheng, M. Minden, 2014, ACS medicinal chemistry letters.

Inhibitors of Stat5 protein signalling

M. Minden, P. Gunning, D. Resetca, 2012 .

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion.

Z. Bago-Horvath, R. Moriggl, V. Sexl, 2016, Cancer discovery.

Progress towards direct inhibitors of Stat5 protein

P. Gunning, Abbarna A. Cumaraswamy, A. Cumaraswamy, 2012, Hormone molecular biology and clinical investigation.

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

T. Rülicke, A. Chott, L. Kenner, 2019, Haematologica.